This company listing is no longer active
Resumen de acción SGFY
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en SGFY a partir de nuestros controles de riesgos.
Competidores de Signify Health, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$30.49 |
| 52 Week High | US$30.50 |
| 52 Week Low | US$10.70 |
| Beta | 0.36 |
| 1 Month Change | 5.90% |
| 3 Month Change | 6.39% |
| 1 Year Change | 67.99% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -3.39% |
Noticias y actualizaciones recientes
CVS Health to offer bonds to finance purchase of Signify Health
Feb 13Signify Health and Prospect Medical come together to deliver coordinated, high-quality care
Jan 11Checking Signify Health Before The CVS Transaction
Dec 21Recent updates
CVS Health to offer bonds to finance purchase of Signify Health
Feb 13Signify Health and Prospect Medical come together to deliver coordinated, high-quality care
Jan 11Checking Signify Health Before The CVS Transaction
Dec 21Signify expands diagnostic offering with spirometry test for lung disease
Oct 18Signify Health jumps on report CVS in talks to acquire for about $8 billion
Sep 02Signify Health: Cathie Wood Now Selling
Aug 15CVS Health seeking purchase of Signify Health - WSJ
Aug 07Signify Health: ECS Wind Down Sheds Light On Compelling Valuation
Jul 21Signify Health Aims Higher With New CMS Terms
Mar 16Revisiting Signify Health
Jan 09Signify Health names Susan Yun as chief people officer
Jun 02Rentabilidad de los accionistas
| SGFY | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | 5.5% | 0.5% | 3.3% |
| 1Y | 68.0% | 2.0% | 25.8% |
Rentabilidad vs. Industria: SGFY exceeded the US Healthcare industry which returned -14.7% over the past year.
Rentabilidad vs. Mercado: SGFY exceeded the US Market which returned -16% over the past year.
Volatilidad de los precios
| SGFY volatility | |
|---|---|
| SGFY Average Weekly Movement | 2.0% |
| Healthcare Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: SGFY has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: SGFY's weekly volatility has decreased from 8% to 2% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2017 | 2,150 | Bradford Armbrester | www.signifyhealth.com |
Resumen de fundamentos de Signify Health, Inc.
| Estadísticas fundamentales de SGFY | |
|---|---|
| Capitalización bursátil | US$7.21b |
| Beneficios(TTM) | US$76.50m |
| Ingresos (TTM) | US$805.50m |
71.4x
Ratio precio-beneficio (PE)6.8x
Ratio precio-ventas (PS)¿Está SGFY sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de SGFY | |
|---|---|
| Ingresos | US$805.50m |
| Coste de los ingresos | US$440.40m |
| Beneficio bruto | US$365.10m |
| Otros gastos | US$288.60m |
| Beneficios | US$76.50m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.43 |
| Margen bruto | 45.33% |
| Margen de beneficio neto | 9.50% |
| Ratio deuda/patrimonio | 41.0% |
¿Cómo se ha desempeñado SGFY a largo plazo?
Ver rendimiento histórico y comparativa